Stefan Bielack
- Pulmonary and Respiratory Medicine top 0.05%
- Sarcoma Diagnosis and Treatment 158
- Rheumatology top 0.1%
- Bone Tumor Diagnosis and Treatments 63
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 20
- Oncology top 0.5%
- Vascular Tumors and Angiosarcomas 26
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 27
-
- Cardiac tumors and thrombi 30
-
- Childhood Cancer Survivors' Quality of Life 19
-
- Neuroblastoma Research and Treatments 18
Stefan Bielack
211 papers receiving 13.8k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Pulmonary and Respiratory Medicine 8.6k
- Rheumatology 3.8k
- Cancer Research 2.6k
- Oncology 3.8k
- Pathology and Forensic Medicine 1.5k
Countries citing papers authored by Stefan Bielack
This map shows the geographic impact of Stefan Bielack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Bielack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Bielack more than expected).
Fields of papers citing papers by Stefan Bielack
This network shows the impact of papers produced by Stefan Bielack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Bielack. The network helps show where Stefan Bielack may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stefan Bielack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 7 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 7 | |
| 10 | Osteosarcomabreakdown → | 2022 | 337 |
| 11 | 2020 | 33 | |
| 12 | 2020 | 7 | |
| 13 | 2018 | 32 | |
| 14 | 2016 | 11 | |
| 15 | Report of the CWS 2002P Study : Treatment Results for Soft Tissue Sarcomas (STS) in Childhood and Adolescence | 2013 | 11 |
| 16 | Improved radiologic assessment of children with soft tissue sarcoma in the framework of the cooperative weichteilsarkom studiengruppe (CWS) | 2012 | 1 |
| 17 | SURVIVAL AFTER RECURRENCE OF METASTATIC RHAFIDOMYOSARCOMA - AN UNPROBABLE, BUT NOT IMPOSSIBLE EVENT IN THE EXPERIENCE OF THE COOPERATIVE WEICHTEILSARKOM STUDIENGRUPPE (CWS) | 2010 | 1 |
| 18 | 2008 | 167 | |
| 19 | 2006 | 2 | |
| 20 | 2005 | 53 |
About Stefan Bielack
Stefan Bielack is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Pathology and Forensic Medicine, having authored 215 papers that have together received 14.0k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (158 papers), Bone Tumor Diagnosis and Treatments (63 papers), Cardiac tumors and thrombi (30 papers), Lymphoma Diagnosis and Treatment (27 papers), Vascular Tumors and Angiosarcomas (26 papers), Cancer Genomics and Diagnostics (20 papers), Childhood Cancer Survivors' Quality of Life (19 papers) and Neuroblastoma Research and Treatments (18 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (8.6k citations), Rheumatology (3.8k citations) and Cancer Research (2.6k citations). Stefan Bielack has collaborated with scholars based in Germany, Austria and Switzerland. Frequent co-authors include J. Ritter, Heribert Jürgens, Richard Görlick, R. Kotz, Paul S. Meltzer, Michael S. Isakoff, Beate Kempf‐Bielack, D. Carrle, A. Zoubek and Winfried Winkelmann. Their work appears in journals such as Pediatric Blood & Cancer, Journal of Clinical Oncology, Annals of Oncology, Cancer and Cancer treatment and research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.